45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
4,741
Insurances with rates
7
CPT / HCPCS codes
3,305
Most expensive procedures (gross)
J1823
$235,154
inebilizumab-cdon 10 mg/mL Soln 10 mL Vial
Gross
$313,538
J9226
$230,337
histrelin (SUPPRELIN LA) 50 mg (65 mcg/day) Kit 1 Each KIT
Gross
$307,117
0278
$228,588
Ventricular Assist Devices
Gross
$304,784
J0802
$227,221
corticotropin 80 unit/mL Gel 5 mL Vial
Gross
$302,961
J1305
$223,339
evinacumab-dgnb 150 mg/mL Soln 8 mL Vial
Gross
$297,786
J2351
$211,473
ocrelizumab-hyaluronidase-ocsq 920 mg-23,000 unit/23 mL Soln 23 mL Vial
Gross
$281,963
J1289
$179,222
narsoplimab-wuug 370 mg/2 mL (185 mg/mL) Soln 2 mL Vial
Gross
$238,963
J0567
$174,689
cerliponase alfa 150 mg/5 mL Soln 5 mL Vial
Gross
$232,919
0812
$171,065
Acquisition of Body Components-Cadaver Donor
Gross
$228,087
J1951
$140,320
leuprolide 45 mg Syrg 1 Each Syringe
Gross
$187,093
0811
$130,466
Acquisition of Body Components-Living Donor
Gross
$173,955
J9348
$126,934
naxitamab 4 mg/mL Soln 10 mL Vial
Gross
$169,245
33270
$122,330
Ins/Rplcmnt Perm Subq Impltbl Dfb W/Subq Eltrd
Gross
$163,106
33289
$114,663
Tcat Impl Wrls P-Art S Snr L-T Hemodyn Mntr
Gross
$152,884
J3316
$111,843
triptorelin 22.5 mg Susr 1 Each Vial
Gross
$149,124
J0638
$109,189
canakinumab (PF) 150 mg/mL Soln 1 mL Vial
Gross
$145,585
J2350
$105,746
ocrelizumab 30 mg/mL Soln 10 mL Vial
Gross
$140,994
L8686
$93,716
Implantable Nerve Stimulator System or Kit or Accessories
Gross
$124,955
J9210
$90,363
emapalumab-lzsg 5 mg/mL Soln 10 mL Vial
Gross
$120,484
J9118
$89,215
CALaspargase pegol-mknL 750 unit/mL Soln 5 mL Vial
Gross
$118,953
38205
$80,223
Prog Cell Harvest,Transplant,Allogenic
Gross
$106,964
J9334
$79,920
efgartigimod-hyaluronidas-qvfc 1,008 mg-11,200 unit/5.6 mL Soln 5.6 mL Vial
Gross
$106,560
93656
$77,276
Compre Ep Eval Abltj Atr Fib
Gross
$103,035
J3357
$74,537
Ustekinumab 45 mg/0.5 mL Syrg 0.5 mL Syringe
Gross
$99,382
J1628
$74,489
guselkumab 200 mg/20 mL (10 mg/mL) Soln 20 mL Vial
Gross
$99,319
J9229
$71,391
inotuzumab ozogamicin 0.25 mg/mL Solr 1 Each Vial
Gross
$95,188
J9381
$70,186
teplizumab-mzwv 1 mg/mL Soln 20 mL Vial
Gross
$93,581
J1950
$65,857
leuprolide 45 mg Sykt 1 Each KIT
Gross
$87,809
J9042
$64,144
brentuximab vedotin 5 mg/mL Solr 1 Each Vial
Gross
$85,526
0823T
$61,469
Tcat Insj Perm 1chmbr Ldls Pacemaker R Atrial
Gross
$81,959
0825T
$61,469
Tcat Rmvl&Rplcmt Perm 1chmbr Ldls Pm R Atrial
Gross
$81,959
0795T
$61,469
Transcather Insertion of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy and Device Inte
Gross
$81,959
0796T
$61,469
Transcather Insertion of Permanent Dual-Chamber Pacemaker Using Fluoroscopy and Device Interrogation
Gross
$81,959
0797T
$61,469
Transcather Insertion of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy and Device Inte
Gross
$81,959
0801T
$61,469
Transcather Removal and Replacement of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy a
Gross
$81,959
0802T
$61,469
Transcather Removal and Replacement of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy a
Gross
$81,959
0803T
$61,469
Transcather Removal and Replacement of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy a
Gross
$81,959
33902
$59,656
Perq P-Art Revsc St 1st Abnor Connj Unilateral
Gross
$79,541
33274
$59,656
Tcat Insj/Rpl Perm Leadless Pacemaker Rv W/Img
Gross
$79,541
J0208
$58,388
sodium thiosulfate 12.5 gram/100mL (125 mg/mL) Soln 100 mL Vial
Gross
$77,851
J2329
$57,629
ublituximab-xiiy 25 mg/mL Soln 6 mL Vial
Gross
$76,839
J9038
$57,113
axatilimab-csfr 50 mg/mL Soln 0.44 mL Vial
Gross
$76,150
93590
$56,186
Repair of Leak Adjacent to Mitral Valve, First Closure Device
Gross
$74,915
93591
$56,186
Repair of Leak Adjacent to Aortic Valve, First Closure Device
Gross
$74,915
92930
$56,186
Perq Tcat Plmt Ntrac St 2+Les 2+St 2+C Segments
Gross
$74,915
37286
$56,186
Revsc Evasc Tpvt St Plmt Uni Cplx Les 1st Vsl
Gross
$74,915
37288
$56,186
Revsc Evasc Tpvt Athrc Uni Sf Les 1st Vsl
Gross
$74,915
37290
$56,186
Revsc Evasc Tpvt Athrc Uni Sf Les Ea Addl Vsl
Gross
$74,915
37292
$56,186
Revsc Evasc Tpvt St Athrc Uni Sf Les 1st Vsl
Gross
$74,915
37294
$56,186
Revsc Evasc Tpvt St Athrc Uni Cplx Les 1st Vsl
Gross
$74,915
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J1823 | inebilizumab-cdon 10 mg/mL Soln 10 mL Vial | $313,538 | $235,154 | — | — | 13 |
| J9226 | histrelin (SUPPRELIN LA) 50 mg (65 mcg/day) Kit 1 Each KIT | $307,117 | $230,337 | — | — | 13 |
| 0278 | Ventricular Assist Devices | $304,784 | $228,588 | — | — | 109 |
| J0802 | corticotropin 80 unit/mL Gel 5 mL Vial | $302,961 | $227,221 | — | — | 26 |
| J1305 | evinacumab-dgnb 150 mg/mL Soln 8 mL Vial | $297,786 | $223,339 | — | — | 13 |
| J2351 | ocrelizumab-hyaluronidase-ocsq 920 mg-23,000 unit/23 mL Soln 23 mL Vial | $281,963 | $211,473 | — | — | 13 |
| J1289 | narsoplimab-wuug 370 mg/2 mL (185 mg/mL) Soln 2 mL Vial | $238,963 | $179,222 | — | — | 13 |
| J0567 | cerliponase alfa 150 mg/5 mL Soln 5 mL Vial | $232,919 | $174,689 | — | — | 13 |
| 0812 | Acquisition of Body Components-Cadaver Donor | $228,087 | $171,065 | — | — | 38 |
| J1951 | leuprolide 45 mg Syrg 1 Each Syringe | $187,093 | $140,320 | — | — | 13 |
| 0811 | Acquisition of Body Components-Living Donor | $173,955 | $130,466 | — | — | 26 |
| J9348 | naxitamab 4 mg/mL Soln 10 mL Vial | $169,245 | $126,934 | — | — | 13 |
| 33270 | Ins/Rplcmnt Perm Subq Impltbl Dfb W/Subq Eltrd | $163,106 | $122,330 | — | — | 12 |
| 33289 | Tcat Impl Wrls P-Art S Snr L-T Hemodyn Mntr | $152,884 | $114,663 | — | — | 12 |
| J3316 | triptorelin 22.5 mg Susr 1 Each Vial | $149,124 | $111,843 | — | — | 13 |
| J0638 | canakinumab (PF) 150 mg/mL Soln 1 mL Vial | $145,585 | $109,189 | — | — | 13 |
| J2350 | ocrelizumab 30 mg/mL Soln 10 mL Vial | $140,994 | $105,746 | — | — | 13 |
| L8686 | Implantable Nerve Stimulator System or Kit or Accessories | $124,955 | $93,716 | — | — | 51 |
| J9210 | emapalumab-lzsg 5 mg/mL Soln 10 mL Vial | $120,484 | $90,363 | — | — | 13 |
| J9118 | CALaspargase pegol-mknL 750 unit/mL Soln 5 mL Vial | $118,953 | $89,215 | — | — | 13 |
| 38205 | Prog Cell Harvest,Transplant,Allogenic | $106,964 | $80,223 | — | — | 24 |
| J9334 | efgartigimod-hyaluronidas-qvfc 1,008 mg-11,200 unit/5.6 mL Soln 5.6 mL Vial | $106,560 | $79,920 | — | — | 13 |
| 93656 | Compre Ep Eval Abltj Atr Fib | $103,035 | $77,276 | — | — | 12 |
| J3357 | Ustekinumab 45 mg/0.5 mL Syrg 0.5 mL Syringe | $99,382 | $74,537 | — | — | 13 |
| J1628 | guselkumab 200 mg/20 mL (10 mg/mL) Soln 20 mL Vial | $99,319 | $74,489 | — | — | 13 |
| J9229 | inotuzumab ozogamicin 0.25 mg/mL Solr 1 Each Vial | $95,188 | $71,391 | — | — | 13 |
| J9381 | teplizumab-mzwv 1 mg/mL Soln 20 mL Vial | $93,581 | $70,186 | — | — | 13 |
| J1950 | leuprolide 45 mg Sykt 1 Each KIT | $87,809 | $65,857 | — | — | 26 |
| J9042 | brentuximab vedotin 5 mg/mL Solr 1 Each Vial | $85,526 | $64,144 | — | — | 13 |
| 0823T | Tcat Insj Perm 1chmbr Ldls Pacemaker R Atrial | $81,959 | $61,469 | — | — | 12 |
| 0825T | Tcat Rmvl&Rplcmt Perm 1chmbr Ldls Pm R Atrial | $81,959 | $61,469 | — | — | 12 |
| 0795T | Transcather Insertion of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy and Device Inte | $81,959 | $61,469 | — | — | 12 |
| 0796T | Transcather Insertion of Permanent Dual-Chamber Pacemaker Using Fluoroscopy and Device Interrogation | $81,959 | $61,469 | — | — | 12 |
| 0797T | Transcather Insertion of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy and Device Inte | $81,959 | $61,469 | — | — | 12 |
| 0801T | Transcather Removal and Replacement of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy a | $81,959 | $61,469 | — | — | 12 |
| 0802T | Transcather Removal and Replacement of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy a | $81,959 | $61,469 | — | — | 12 |
| 0803T | Transcather Removal and Replacement of Permanent Dual-Chamber Leadless Pacemaker Using Fluoroscopy a | $81,959 | $61,469 | — | — | 12 |
| 33902 | Perq P-Art Revsc St 1st Abnor Connj Unilateral | $79,541 | $59,656 | — | — | 12 |
| 33274 | Tcat Insj/Rpl Perm Leadless Pacemaker Rv W/Img | $79,541 | $59,656 | — | — | 12 |
| J0208 | sodium thiosulfate 12.5 gram/100mL (125 mg/mL) Soln 100 mL Vial | $77,851 | $58,388 | — | — | 13 |
| J2329 | ublituximab-xiiy 25 mg/mL Soln 6 mL Vial | $76,839 | $57,629 | — | — | 13 |
| J9038 | axatilimab-csfr 50 mg/mL Soln 0.44 mL Vial | $76,150 | $57,113 | — | — | 13 |
| 93590 | Repair of Leak Adjacent to Mitral Valve, First Closure Device | $74,915 | $56,186 | — | — | 12 |
| 93591 | Repair of Leak Adjacent to Aortic Valve, First Closure Device | $74,915 | $56,186 | — | — | 12 |
| 92930 | Perq Tcat Plmt Ntrac St 2+Les 2+St 2+C Segments | $74,915 | $56,186 | — | — | 12 |
| 37286 | Revsc Evasc Tpvt St Plmt Uni Cplx Les 1st Vsl | $74,915 | $56,186 | — | — | 12 |
| 37288 | Revsc Evasc Tpvt Athrc Uni Sf Les 1st Vsl | $74,915 | $56,186 | — | — | 12 |
| 37290 | Revsc Evasc Tpvt Athrc Uni Sf Les Ea Addl Vsl | $74,915 | $56,186 | — | — | 12 |
| 37292 | Revsc Evasc Tpvt St Athrc Uni Sf Les 1st Vsl | $74,915 | $56,186 | — | — | 12 |
| 37294 | Revsc Evasc Tpvt St Athrc Uni Cplx Les 1st Vsl | $74,915 | $56,186 | — | — | 12 |
Showing top 50 of 4,741 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.